Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-092-0 | CAS number: 25549-16-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Toxicokinetik analysis of Triisooctylamine (CAS 25549-16-0)
The test substance is an UVCB substance appearing as colorless clear liquid at room temperature with a molecular weight of 353.67 g/mol and a relative density of 0.816. The test substance has a melting point below -107 °C. A boiling point could not be determined due to limited stability. The substance is moderately soluble in water, as water solubility was determined to be 0.031 and 0.146 g/L at 20 °C with a loading rate of 1 g/L and 10 g/L, respectively. Partition coefficient (logPow) of the main constituent was estimated by QSAR calculation to be 10.13 and is thus too high for determination by experimental study. Vapor pressure of the substance was determined to be 0.000927 Pa at 20 °C.
1.1 Absorption
Oral route
Bioavailability via oral route is strongly linked to physico-chemical properties of the substance (ECHA Guidance, 2008). Generally, oral absorption is favored for molecular weights below 500 g/mol and with a logPow in the range of -1 to 4. Thus, with an estimated logPow of 10 and a molecular weight of 353.67 g/mol, the substance is expected to be not readily absorbed. Furthermore, the substance is only moderately soluble in water. Based on its structure, the substance is not expected to undergo hydrolysis (please refer also to IUCLID Section 5.1.2.). Taken together, the physico-chemical properties of the substance indicate that intestinal absorption might not be favored but cannot be ruled out completely. Therefore, the test substance is expected to be absorbed to a small extend, even though not readily.
The above considerations are confirmed by findings of toxicity studies with the test substance. Experimental toxicity data indicate that the substance induces toxicity in rats when applied via the oral route, giving clear indication that the substance is absorbed in the GI tract. In an acute oral toxicity study with rats, mortality was observed at 2000 mg/kg bw. LD50 was determined to be > 300 and < 2000 mg/kg bw. A combined repeated dose toxicity study with the reproduction/developmental toxicity screening test together with an additional 28 days repeated dose toxicity study in male rats also revealed signs of toxicity resulting in a NOAEL of 10 mg/kg bw/d. These observations give clear indication that the substance has been absorbed in the GI tract despite its not favorable physico-chemical properties.
Dermal route
Regarding dermal application,
physico-chemical properties of the test item indicate that it probably
does not becomes readily bioavailable. According to ECHA guidance on
toxicokinetics, there are no exclusion criteria for skin permeability
(ECHA, 2017). However, a molecular weight of > 500 Da and a log Pow of >
4 are given as indicators for low absorption (10% or less). Considering
the calculated log Pow of 10, the latter criteria is fulfilled by the
test item. The molecular weight of 353.67 g/mol, however, could still
support dermal absorption. The same applies for water solubility which
favors a low to moderate dermal absorption being between ca. 30 and 150
mg/L.
Based on the findings of an acute dermal toxicity study no signs
toxicity were observed when the limit dose of 2000 mg/kg bw was applied
to rat skin. Even though local effects of skin irritation were observed
(classified as skin irritant cat. 2), no signs of systemic toxicity were
recorded as observed in the acute oral toxicity study at doses as low as
300 mg/kg. This supports the assumption that the substance becomes
bioavailable to a less extent via the dermal route. However, the
substance has been identified as skin sensitizer indicating that at
least some dermal uptake takes place. This is probably accomplished by
tissue damage due to irritating properties of the test item.
Inhalation route
Due to a very low vapor pressure of 0,000927 Pa it is very unlikely that the substance is available as a vapor. Boiling point of the substance could not be determined due to technical reasons of limited stability. Therefore, regarding inhalation, exposure is not relevant since the substance is a non-volatile liquid. However, in the case of inhalation the substance is expected to not easily pass biological membranes of the respiratory tract based on the same indications as outlined above.
1.3 Distribution
As mentioned before, only moderate bioavailability is expected for the test item. When absorbed, distribution is expected to occur rather via plasma protein binding based on moderate water solubility and high logPow of the substance. Furthermore, the substance is not expected to bioaccumulate as indicated by several QSAR calculations.
1.4 Metabolism
Considering the chemical structure of the test item, enzymatic transformation would be plausible. Non-enzymatic hydrolysis and/or oxidation are not expected.
Tertiary amines are metabolised primarily by cytochrome P450 enzymes to alpha-C oxidation or N-Oxidation (Rose & Castagnoli, 1983). N-oxides that may be formed are probably further inactivated by reducing enzymes and anti-oxidizing substrates such as glutathione (GSH). Further, N-Acetyltransferases (NATs) may accomplish acetylation of the primary amine function which will not necessarily increase hydrophilicity but masks the amine function. The branched or linear carbon chain may be oxidized by phase I metabolising enzymes. The resulting carbon acid chains may be further degraded by endogenous fatty acid beta-oxidation pathway.
In vitro test systems applying exogenous metabolic activation systems (S9 mix), such as the HPRT assay, revealed an increased cytotoxicity of the test item to mammalian cells when S9 was not added compared to the runs where S9 was applied. This indicates that a metabolic deactivation of the test item takes place in vitro and probably also in vivo.
Oxidative metabolism occurs most prominently in the liver which is in line with the adaptive liver weight increase observed in female rats at the highest dose tested in the respective repeated dose toxicity study.
1.5 Elimination
Based on its molecular weight, the test item is expected to be elimination predominantly via the kidney. Further, metabolic transformation should in general lead to an increased hydrophilicity and thus support excretion via urine. The hydrocarbon chains are integrated and transformed in the endogenous pathways of energy metabolism and eliminated, accordingly.
2. Summary
Based on its physicochemical properties, particularly moderate water solubility, high logPow and molecular weight, absorption via the gastrointestinal tract is not favored for the test item. However, toxicity studies in vivo give clear indication that the test item becomes bioavailable via the oral route. In contrast, uptake of relevant amounts following dermal exposure is considered to take place to very less extent. This is supported by the lack of findings in an acute dermal toxicity study. Based on its very low vapor pressure it is highly unlikely that the test item will be available via the inhalation route. The test item is probably distributed by plasma protein binding due to its low water solubility. Bioaccumulation is not expected. The test item is not considered to undergo relevant abiotic transformation. However, metabolic transformation and inactivation of the test item is indicated by findings of in vitro tests and therefore anticipated. Degradation products are probably recycled in the endogenous metabolic pathway and or eliminated via the urine.
References
ECHA Guidance on Information requirements and Chemical Safety Assessment, Chapter R 7c Endpoint specific guidance Version 3.0, 2017
Rose, J. and Castagnoli N, Jr. “The metabolism of tertiary amines”. Med. Res. Rev., 1983 Jan-Mar, 3 (1):73-88
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.